Study Finds Single-Dose Lysin Shows Promise Against S. Aureus

Healio (10/2, Downey) reported, “Patients with Staphylococcus aureus who were treated with exebacase, a recombinantly produced lysin, achieved symptom resolution in half the time compared with participants who received placebo, researchers reported at IDW...